Department of Psychology, Yale University, New Haven, Connecticut.
Hotchkiss Brain Institute, Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada.
JAMA Psychiatry. 2018 Sep 1;75(9):960-968. doi: 10.1001/jamapsychiatry.2018.1543.
Altered neurodevelopmental trajectories are thought to reflect heterogeneity in the pathophysiologic characteristics of schizophrenia, but whether neural indicators of these trajectories are associated with future psychosis is unclear.
To investigate distinct neuroanatomical markers that can differentiate aberrant neurodevelopmental trajectories among clinically high-risk (CHR) individuals.
DESIGN, SETTING, AND PARTICIPANTS: In this prospective longitudinal multicenter study, a neuroanatomical-based age prediction model was developed using a supervised machine learning technique with T1-weighted magnetic resonance imaging scans of 953 healthy controls 3 to 21 years of age from the Pediatric Imaging, Neurocognition, and Genetics (PING) study and then applied to scans of 275 CHR individuals (including 39 who developed psychosis) and 109 healthy controls 12 to 21 years of age from the North American Prodrome Longitudinal Study 2 (NAPLS 2) for external validation and clinical application. Scans from NAPLS 2 were collected from January 15, 2010, to April 30, 2012.
Discrepancy between neuroanatomical-based predicted age (hereafter referred to as brain age) and chronological age.
The PING-derived model (460 females and 493 males; age range, 3-21 years) accurately estimated the chronological ages of the 109 healthy controls in the NAPLS 2 (43 females and 66 males; age range, 12-21 years), providing evidence of independent external validation. The 275 CHR individuals in the NAPLS 2 (111 females and 164 males; age range, 12-21 years) showed a significantly greater mean (SD) gap between model-predicted age and chronological age (0.64 [2.16] years) compared with healthy controls (P = .008). This outcome was significantly moderated by chronological age, with brain age systematically overestimating the ages of CHR individuals who developed psychosis at ages 12 to 17 years but not the brain ages of those aged 18 to 21 years. Greater brain age deviation was associated with a higher risk for developing psychosis (F = 3.70; P = .01) and a pattern of stably poor functioning over time, but only among younger CHR adolescents. Previously reported evidence of accelerated reduction in cortical thickness among CHR individuals who developed psychosis was found to apply only to those who were 18 years of age or older.
These results are consistent with the view that neuroanatomical markers of schizophrenia may help to explain some of the heterogeneity of this disorder, particularly with respect to early vs later age of onset of psychosis, with younger and older individuals having differing intercepts and trajectories in structural brain parameters as a function of age. The results also suggest that baseline neuroanatomical measures are likely to be useful in estimating onset of psychosis, especially (or only) among CHR individuals with an earlier age of onset of prodromal symptoms.
据认为,神经发育轨迹的改变反映了精神分裂症病理生理特征的异质性,但这些轨迹的神经指标是否与未来的精神病有关尚不清楚。
研究可区分临床高风险(CHR)个体中异常神经发育轨迹的不同神经解剖学标志物。
设计、地点和参与者:在这项前瞻性纵向多中心研究中,使用基于监督机器学习技术,对来自儿科影像学、神经认知和遗传学(PING)研究的 953 名 3 至 21 岁的健康对照者的 T1 加权磁共振成像扫描进行了神经解剖学年龄预测模型的开发,然后将其应用于 275 名 CHR 个体(包括 39 名发展为精神病的个体)和来自北美前驱期纵向研究 2(NAPLS 2)的 109 名 12 至 21 岁的健康对照者的扫描中,以进行外部验证和临床应用。NAPLS 2 的扫描数据于 2010 年 1 月 15 日至 2012 年 4 月 30 日收集。
神经解剖学基础预测年龄(以下简称大脑年龄)与实际年龄之间的差异。
PING 衍生模型(460 名女性和 493 名男性;年龄范围为 3-21 岁)准确估计了 NAPLS 2 中 109 名健康对照者的实际年龄(43 名女性和 66 名男性;年龄范围为 12-21 岁),提供了独立外部验证的证据。NAPLS 2 中的 275 名 CHR 个体(111 名女性和 164 名男性;年龄范围为 12-21 岁)与健康对照组(P=0.008)相比,模型预测年龄与实际年龄之间的平均(SD)差距更大(0.64[2.16]岁)。这一结果显著受到实际年龄的调节,大脑年龄系统地高估了 12 至 17 岁时发生精神病的 CHR 个体的年龄,但没有高估 18 至 21 岁时发生精神病的 CHR 个体的大脑年龄。更大的大脑年龄偏差与更高的精神病发病风险相关(F=3.70;P=0.01),以及随着时间的推移功能稳定恶化的模式,但仅在较年轻的 CHR 青少年中如此。此前报道的 CHR 个体中精神病发生时皮质厚度加速减少的证据仅适用于 18 岁或以上的个体。
这些结果与神经解剖学标志物可能有助于解释该疾病的一些异质性的观点一致,特别是在精神病发病的年龄方面,年轻和年长个体的结构脑参数的截距和轨迹因年龄而异。结果还表明,基线神经解剖学测量值可能有助于估计精神病的发病时间,尤其是(或仅)在发病前症状出现年龄较早的 CHR 个体中。